1 Market Overview

1.1 Product Overview and Scope of Epigenetic

1.2 Classification of Epigenetic by Type

1.2.1 Overview: Global Epigenetic Market Size by Type: 2022 Versus 2028

1.2.2 Global Epigenetic Revenue Market Share by Type in 2028

1.2.3 Reagents

1.2.4 Kits

1.2.5 Instruments

1.2.6 Enzymes

1.2.7 Services

1.3 Global Epigenetic Market by Application

1.3.1 Overview: Global Epigenetic Market Size by Application: 2022 Versus 2028

1.3.2 Academic Research Institutes

1.3.3 Biotechnology Companies

1.3.4 Biopharmaceutical Companies

1.3.5 Diagnostic Companies

1.4 Global Epigenetic Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Epigenetic Market Drivers

1.5.2 Epigenetic Market Restraints

1.5.3 Epigenetic Trends Analysis

2 Company Profiles

2.1 Illumina

2.1.1 Illumina Details

2.1.2 Illumina Major Business

2.1.3 Illumina Epigenetic Product and Solutions

2.1.4 Illumina Recent Developments and Future Plans

2.2 Qiagen

2.2.1 Qiagen Details

2.2.2 Qiagen Major Business

2.2.3 Qiagen Epigenetic Product and Solutions

2.2.4 Qiagen Recent Developments and Future Plans

2.3 Abcam

2.3.1 Abcam Details

2.3.2 Abcam Major Business

2.3.3 Abcam Epigenetic Product and Solutions

2.3.4 Abcam Recent Developments and Future Plans

2.4 Merck & Co

2.4.1 Merck & Co Details

2.4.2 Merck & Co Major Business

2.4.3 Merck & Co Epigenetic Product and Solutions

2.4.4 Merck & Co Recent Developments and Future Plans

2.5 Sigma-Aldrich

2.5.1 Sigma-Aldrich Details

2.5.2 Sigma-Aldrich Major Business

2.5.3 Sigma-Aldrich Epigenetic Product and Solutions

2.5.4 Sigma-Aldrich Recent Developments and Future Plans

2.6 New England Biolabs

2.6.1 New England Biolabs Details

2.6.2 New England Biolabs Major Business

2.6.3 New England Biolabs Epigenetic Product and Solutions

2.6.4 New England Biolabs Recent Developments and Future Plans

2.7 Thermo Fisher Scientific

2.7.1 Thermo Fisher Scientific Details

2.7.2 Thermo Fisher Scientific Major Business

2.7.3 Thermo Fisher Scientific Epigenetic Product and Solutions

2.7.4 Thermo Fisher Scientific Recent Developments and Future Plans

2.8 Diagenode

2.8.1 Diagenode Details

2.8.2 Diagenode Major Business

2.8.3 Diagenode Epigenetic Product and Solutions

2.8.4 Diagenode Recent Developments and Future Plans

2.9 Active Motif

2.9.1 Active Motif Details

2.9.2 Active Motif Major Business

2.9.3 Active Motif Epigenetic Product and Solutions

2.9.4 Active Motif Recent Developments and Future Plans

2.10 Roche Diagnostics

2.10.1 Roche Diagnostics Details

2.10.2 Roche Diagnostics Major Business

2.10.3 Roche Diagnostics Epigenetic Product and Solutions

2.10.4 Roche Diagnostics Recent Developments and Future Plans

2.11 Eisai

2.11.1 Eisai Details

2.11.2 Eisai Major Business

2.11.3 Eisai Epigenetic Product and Solutions

2.11.4 Eisai Recent Developments and Future Plans

2.12 Novartis

2.12.1 Novartis Details

2.12.2 Novartis Major Business

2.12.3 Novartis Epigenetic Product and Solutions

2.12.4 Novartis Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Epigenetic Revenue and Share by Players (2022 & 2028)

3.2 Epigenetic Players Head Office, Products and Services Provided

3.3 Epigenetic Mergers & Acquisitions

3.4 Epigenetic New Entrants and Expansion Plans

4 Global Epigenetic Forecast by Region

4.1 Global Epigenetic Market Size by Region: 2022 VS 2028

4.2 Global Epigenetic Market Size by Region, (2022-2028)

4.3 North America

4.3.1 Key Companies of Epigenetic in North America

4.3.2 Current Situation and Forecast of Epigenetic in North America

4.3.3 North America Epigenetic Market Size and Prospect (2022-2028)

4.4 Europe

4.4.1 Key Companies of Epigenetic in Europe

4.4.2 Current Situation and Forecast of Epigenetic in Europe

4.4.3 Europe Epigenetic Market Size and Prospect (2022-2028)

4.5 Asia-Pacific

4.5.1 Key Companies of Epigenetic in Asia-Pacific

4.5.2 Current Situation and Forecast of Epigenetic in Asia-Pacific

4.5.3 Asia-Pacific Epigenetic Market Size and Prospect (2022-2028)

4.6 South America

4.6.1 Key Companies of Epigenetic in South America

4.6.2 Current Situation and Forecast of Epigenetic in South America

4.6.3 South America Epigenetic Market Size and Prospect (2022-2028)

4.7 Middle East & Africa

4.7.1 Key Companies of Epigenetic in Middle East & Africa

4.7.2 Current Situation and Forecast of Epigenetic in Middle East & Africa

4.7.3 Middle East & Africa Epigenetic Market Size and Prospect (2022-2028)

5 Market Size Segment by Type

5.1 Global Epigenetic Market Forecast by Type (2022-2028)

5.2 Global Epigenetic Market Share Forecast by Type (2022-2028)

6 Market Size Segment by Application

6.1 Global Epigenetic Market Forecast by Application (2022-2028)

6.2 Global Epigenetic Market Share Forecast by Application (2022-2028)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Epigenetic Revenue by Type, (USD Million), 2022 VS 2028

Table 2. Global Epigenetic Revenue by Application, (USD Million), 2022 VS 2028

Table 3. Illumina Corporate Information, Head Office, and Major Competitors

Table 4. Illumina Major Business

Table 5. Illumina Epigenetic Product and Solutions

Table 6. Qiagen Corporate Information, Head Office, and Major Competitors

Table 7. Qiagen Major Business

Table 8. Qiagen Epigenetic Product and Solutions

Table 9. Abcam Corporate Information, Head Office, and Major Competitors

Table 10. Abcam Major Business

Table 11. Abcam Epigenetic Product and Solutions

Table 12. Merck & Co Corporate Information, Head Office, and Major Competitors

Table 13. Merck & Co Major Business

Table 14. Merck & Co Epigenetic Product and Solutions

Table 15. Sigma-Aldrich Corporate Information, Head Office, and Major Competitors

Table 16. Sigma-Aldrich Major Business

Table 17. Sigma-Aldrich Epigenetic Product and Solutions

Table 18. New England Biolabs Corporate Information, Head Office, and Major Competitors

Table 19. New England Biolabs Major Business

Table 20. New England Biolabs Epigenetic Product and Solutions

Table 21. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 22. Thermo Fisher Scientific Major Business

Table 23. Thermo Fisher Scientific Epigenetic Product and Solutions

Table 24. Diagenode Corporate Information, Head Office, and Major Competitors

Table 25. Diagenode Major Business

Table 26. Diagenode Epigenetic Product and Solutions

Table 27. Active Motif Corporate Information, Head Office, and Major Competitors

Table 28. Active Motif Major Business

Table 29. Active Motif Epigenetic Product and Solutions

Table 30. Roche Diagnostics Corporate Information, Head Office, and Major Competitors

Table 31. Roche Diagnostics Major Business

Table 32. Roche Diagnostics Epigenetic Product and Solutions

Table 33. Eisai Corporate Information, Head Office, and Major Competitors

Table 34. Eisai Major Business

Table 35. Eisai Epigenetic Product and Solutions

Table 36. Novartis Corporate Information, Head Office, and Major Competitors

Table 37. Novartis Major Business

Table 38. Novartis Epigenetic Product and Solutions

Table 39. Global Epigenetic Revenue (USD Million) by Players (2022 & 2028)

Table 40. Global Epigenetic Revenue Share by Players (2022 & 2028)

Table 41. Epigenetic Players Head Office, Products and Services Provided

Table 42. Epigenetic Mergers & Acquisitions in the Past Five Years

Table 43. Epigenetic New Entrants and Expansion Plans

Table 44. Global Market Epigenetic Revenue (USD Million) Comparison by Region (2022 VS 2028)

Table 45. Global Epigenetic Revenue Market Share by Region (2022-2028)

Table 46. Key Companies of Epigenetic in North America

Table 47. Current Situation and Forecast of Epigenetic in North America

Table 48. Key Companies of Epigenetic in Europe

Table 49. Current Situation and Forecast of Epigenetic in Europe

Table 50. Key Companies of Epigenetic in Asia-Pacific

Table 51. Current Situation and Forecast of Epigenetic in Asia-Pacific

Table 52. Key Companies of Epigenetic in China

Table 53. Key Companies of Epigenetic in Japan

Table 54. Key Companies of Epigenetic in South Korea

Table 55. Key Companies of Epigenetic in South America

Table 56. Current Situation and Forecast of Epigenetic in South America

Table 57. Key Companies of Epigenetic in Middle East & Africa

Table 58. Current Situation and Forecast of Epigenetic in Middle East & Africa

Table 59. Global Epigenetic Revenue Forecast by Type (2022-2028)

Table 60. Global Epigenetic Revenue Forecast by Application (2022-2028)

List of Figures

Figure 1. Epigenetic Picture

Figure 2. Global Epigenetic Revenue Market Share by Type in 2028

Figure 3. Reagents

Figure 4. Kits

Figure 5. Instruments

Figure 6. Enzymes

Figure 7. Services

Figure 8. Epigenetic Revenue Market Share by Application in 2028

Figure 9. Academic Research Institutes Picture

Figure 10. Biotechnology Companies Picture

Figure 11. Biopharmaceutical Companies Picture

Figure 12. Diagnostic Companies Picture

Figure 13. Global Epigenetic Market Size, (USD Million): 2022 VS 2028

Figure 14. Global Epigenetic Revenue and Forecast (2022-2028) & (USD Million)

Figure 15. Epigenetic Market Drivers

Figure 16. Epigenetic Market Restraints

Figure 17. Epigenetic Market Trends

Figure 18. Illumina Recent Developments and Future Plans

Figure 19. Qiagen Recent Developments and Future Plans

Figure 20. Abcam Recent Developments and Future Plans

Figure 21. Merck & Co Recent Developments and Future Plans

Figure 22. Sigma-Aldrich Recent Developments and Future Plans

Figure 23. New England Biolabs Recent Developments and Future Plans

Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 25. Diagenode Recent Developments and Future Plans

Figure 26. Active Motif Recent Developments and Future Plans

Figure 27. Roche Diagnostics Recent Developments and Future Plans

Figure 28. Eisai Recent Developments and Future Plans

Figure 29. Novartis Recent Developments and Future Plans

Figure 30. Global Epigenetic Revenue Market Share by Region (2022-2028)

Figure 31. Global Epigenetic Revenue Market Share by Region in 2028

Figure 32. North America Epigenetic Revenue (USD Million) and Growth Rate (2022-2028)

Figure 33. Europe Epigenetic Revenue (USD Million) and Growth Rate (2022-2028)

Figure 34. Asia-Pacific Epigenetic Revenue (USD Million) and Growth Rate (2022-2028)

Figure 35. South America Epigenetic Revenue (USD Million) and Growth Rate (2022-2028)

Figure 36. Middle East & Africa Epigenetic Revenue (USD Million) and Growth Rate (2022-2028)

Figure 37. Global Epigenetic Market Share Forecast by Type (2022-2028)

Figure 38. Global Epigenetic Market Share Forecast by Application (2022-2028)

Figure 39. Methodology

Figure 40. Research Process and Data Source